AJU IB Investment Co., Ltd. Long-Term Concentrated

Location: Seoul, Korea, Republic of

CIK: 0001710065 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 9, 2022

Total Value: $51.65M (100.0% shares, 0.0% debt)

Holdings (7)

ACLX ARCELLX INC 48.3%

Value $24.97M Shares 1,380,890 Est. Cost $16.72 Unrealized -22.8%

KYMR KYMERA THERAPEUTICS INC 17.4%

Value $8.999M Shares 457,059 Est. Cost $48.78 Unrealized -52.1%

SEER SEER INC 14.1%

Value $7.307M Shares 816,375 Est. Cost $63.62 Unrealized -85.6%

— RALLYBIO CORP 11.0%

Value $5.698M Shares 754,678 Est. Cost $9.54 Unrealized —

XLO XILIO THERAPEUTICS INC 3.8%

Value $1.95M Shares 667,742 Est. Cost $17.03 Unrealized -77.8%

— RAPT THERAPEUTICS INC 3.5%

Value $1.816M Shares 99,503 Est. Cost $19.75 Unrealized —

— SUTRO BIOPHARMA INC 1.8%

Value $912K Shares 175,000 Est. Cost $21.71 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC	1,380,890	$24.97M	48.3%	$16.72	-22.8%	COMMON STOCK	03940C100
KYMR	KYMERA THERAPEUTICS INC	457,059	$8.999M	17.4%	$48.78	-52.1%	COM	501575104
SEER	SEER INC	816,375	$7.307M	14.1%	$63.62	-85.6%	COM CL A	81578P106
—	RALLYBIO CORP	754,678	$5.698M	11.0%	$9.54	—	COM	75120L100
XLO	XILIO THERAPEUTICS INC	667,742	$1.95M	3.8%	$17.03	-77.8%	COM	98422T100
—	RAPT THERAPEUTICS INC	99,503	$1.816M	3.5%	$19.75	—	COM	75382E109
—	SUTRO BIOPHARMA INC	175,000	$912K	1.8%	$21.71	—	COM	869367102